Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
* The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Personal Diabetes Manager and Controller are not waterproof.
† The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
‡ Check the Support section of www.librelinkup.com for information about mobile device and operating system compatibility. LibreLinkUp is not intended to be used for dosing decisions or to replace self-monitoring practices as advised by a physician and requires registration with LibreView.
§ In order to receive alarms, the FreeStyle Libre 3 Plus sensor must be connected to the Omnipod 5 System.
|| Currently indicated for Type 1 patients only.
¶ User must be carb aware.
# Based on sensor features including up to 15-day wear period, automatic readings every minute, accuracy data, and single-app setup with AID systems.
## Processing intervals differ by pump. Please check pump’s user manual for reference.
** The WW and FreeStyle Libre 3, FreeStyle Libre 2, FreeStyle Libre 14 day connected experience is compatible with certain mobile operating systems. Please check the Apple App Store or Google Play Store for more information about WW app operating system requirements.
†† The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
‡‡ The app can capture data from the sensor when it is within close proximity of the sensor. The proximity and orientation of the antenna in phones varies and the phone will have to be moved around to find the best position for scanning the sensor.
§§ The user’s device must have internet connectivity for glucose data to be shared with the WW app.
|||| Based on 6-month multicenter trial results from WW Diabetes-Tailored Plan without CGM. Funded by WW International, Inc.
References: 1. Brown, Sue A., et al. “Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.” Diabetes Care 44, no. 7 (2021): 1630–1640. https://doi.org/10.2337/dc21-0172. 2. Sherr, Jennifer L., et al. “Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.” Diabetes Care 45, no. 8 (2022): 1907–1910. https://doi.org/10.2337/dc21-2359. 3. Pasquel, Francisco J., et al. “Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.” JAMA Network Open 8, no. 2 (2025): e2459348. https://doi.org/10.1001/jamanetworkopen.2024.59348. 4. iLet Bionic Pancreas System User Guide. 5. Apolzan, John W., et al. “A Scalable, Virtual Weight Management Program Tailored for Adults With Type 2 Diabetes: Effects on Glycemic Control.” Nutrition & Diabetes 13, no. 3 (2023). https://doi.org/10.1038/s41387-023-00234-6.
Important Safety Information for Insulet Omnipod 5: For full Omnipod safety information, please visit www.omnipod.com/safety.
Important Safety Information for Tandem t:slim X2 insulin pump: For full Tandem safety information, please visit www.tandemdiabetes.com/safetyinfo.
Important Safety Information for iLet Bionic Pancreas System: For full Beta Bionics safety information, please visit www.betabionics.com/safety.
Important Safety Information for Sequel twiist AID System: For full twiist AID System safety information, please visit www.twiist.com/safety.